Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Selina M. Luger, MD

Selina M. Luger, MD Physician

Director, Leukemia Program Professor of Medicine at the Hospital of the University of Pennsylvania

Languages spoken:

  • French

Dr. Luger is employed by Penn Medicine.

About Dr. Selina M. Luger

Recognized by America's Top Doctors, 2013-14

Recognized by Best Doctors in America 2009 - 2016

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1994

Clinical Expertise:

  • Leukemia
  • Stem Cell Transplant

Description of Clinical Expertise

hematologic malignancies, leukemia, AML, ALL, CML, myelodysplastic syndrome, MDS, myeloproliferative disorders, stem cell transplantation, bone marrow transplant

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: McGill University
Residency: Presbyterian University Hospital
Fellowship: Hospital of the University of Pennsylvania


American Society of Clinical Oncology, National American Society of Hematology, National American Society of Hematology, National American Society of Hematology, National Center for International Blood and Marrow Transplant Research (CIBMTR), International Eastern Cooperative Oncology Group, National Royal College of Physicians and Surgeons of Canada, National

Hospital Affiliation

Dr. Luger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Leukemia, myelodysplastic syndrome, myeloproliferative disorders

Selected Publications:

Tasian SK1, Hurtz C2, Wertheim GB3, Bailey NG4, Lim MS4, Harvey RC5, Chen IM5, Willman CL5, Astles R2, Zebrowski A2, Reshmi SC6, Li MM7, Frey NV2, Luger SM2, Carroll M2, Perl AE2.: High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL. Leukemia. 31 (4): 981-984,2017.

Miller Tamara P, Li Yimei, Kavcic Marko, Getz Kelly D, Huang Yuan-Shun V, Sung Lillian, Alonzo Todd A, Gerbing Robert, Daves Marla H, Horton Terzah M, Pulsipher Michael A, Pollard Jessica, Bagatell Rochelle, Seif Alix E, Fisher Brian T, Luger Selina, Gamis Alan S, Adamson Peter C, Aplenc Richard: Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica 102 (9): e340-e343,2017.

Strickland Stephen A, Sun Zhuoxin, Ketterling Rhett P, Cherry Athena M, Cripe Larry D, Dewald Gordon, Fernandez Hugo F, Hicks Gary A, Higgins Rodney R, Lazarus Hillard M, Litzow Mark R, Luger Selina M, Paietta Elisabeth M, Rowe Jacob M, Vance Gail H, Wiernik Peter, Wiktor Anne E, Zhang Yanming, Tallman Martin S: Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. Leukemia research 59 : 55-64,2017.

Stock W1, 2, Diouf B3, 4, Crews KR3, 4, Pei D3, 5, Cheng C3, 5, Laumann K2, 6, Mandrekar SJ2, 6, Luger S7, Advani A8, Stone RM2, Larson RA1, 2, Evans WE3, 4.: An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia. Clin Pharmacol Ther. 101 (3): 391-395,2017.

Alexander B Pine,1 Eun-Ju Lee,2 Mikkael Sekeres,3 David P Steensma,4 Daniel Zelterman,5 Thomas Prebet,2 Amy DeZern,6 Rami Komrokji,7 Mark Litzow,8 Selina Luger,9 Richard Stone,4 Harry P Erba,10 Guillermo Garcia-Manero,11 Alfred I Lee,2 Nikolai A Podoltsev,2 Lisa Barbarotta,1 Stephanie Kasberg,1 Jeanne E Hendrickson,12 Steven D Gore,2 and Amer M Zeidan2: Wide Variations in Blood Product Transfusion Practices among Providers Who Care for Patients with Acute Leukemia in the United States Transfusion 57 (2): 289-295,2017.

Roberts KG1, Gu Z1, Payne-Turner D1, McCastlain K1, Harvey RC1, Chen IM1, Pei D1, Iacobucci I1, Valentine M1, Pounds SB1, Shi L1, Li Y1, Zhang J1, Cheng C1, Rambaldi A1, Tosi M1, Spinelli O1, Radich JP1, Minden MD1, Rowe JM1, Luger S1, Litzow MR1, Tallman MS1, Wiernik PH1, Bhatia R1, Aldoss I1, Kohlschmidt J1, Mrózek K1, Marcucci G1, Bloomfield CD1, Stock W1, Kornblau S1, Kantarjian HM1, Konopleva M1, Paietta E1, Willman CL1, Mullighan CG1.: High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. J Clin Oncol. 35 (4): 394-401,2017.

Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ: Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biol Blood Marrow Transplant. 22 (2): 248-57,2016.

Zhang J1, McCastlain K2, Yoshihara H2, Xu B1, Chang Y2, Churchman ML2, Wu G1, Li Y1, Wei L1, 2, Iacobucci I2, Liu Y1, Qu C1, Wen J1, Edmonson M1, Payne-Turner D2, Kaufmann KB3, Takayanagi SI3, 4, Wienholds E3, Waanders E2, 5, Ntziachristos P6, Bakogianni S6, Wang J6, Aifantis I6, 7, Roberts KG2, Ma J2, Song G2, Easton J1, Mulder HL1, Chen X1, Newman S1, Ma X1, Rusch M1, Gupta P1, Boggs K1, Vadodaria B1, Dalton J2, Liu Y2, Valentine ML8, Ding L9, Lu C9, Fulton RS9, Fulton L9, Tabib Y9, Ochoa K9, Devidas M10: Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 48 (12): 1481-1489,2016.

Gu Z1, Churchman M1, Roberts K1, Li Y2, Liu Y2, Harvey RC3, McCastlain K1, Reshmi SC4, Payne-Turner D1, Iacobucci I1, Shao Y1, 2, Chen IM3, Valentine M5, Pei D6, Mungall KL7, Mungall AJ7, Ma Y7, Moore R7, Marra M7, Stonerock E8, 9, 10, Gastier-Foster JM8, 9, 10, Devidas M11, Dai Y11, Wood B12, Borowitz M13, Larsen EE14, Maloney K15, Mattano LA Jr16, Angiolillo A17, Salzer WL18, Burke MJ19, Gianni F20, Spinelli O20, Radich JP21, Minden MD22, Moorman AV23, Patel B24, Fielding AK25, Rowe JM26, Luger SM27, 31: Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. 7 : 13331,2016.

Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM, Litzow MR, Lee JW, Luger SM, Lazarus HM, Cripe LD, Wiernik PH, Tallman MS: Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. J Clin Oncol. 34 (29): 3544-3553,2016.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-101
34th and Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1847
Patient appointments: 800-789-7366 (PENN)

Related Links